Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast for monoclonal antibody infusion reactions
NCT04198623Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- Mar 2020
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of montelukast in infusion reaction, sponsored by University of California, San Francisco. Started Mar 2020; status: completed.
02
Drugs
montelukast
03
Conditions
infusion reaction
Beyond the preview
Go deeper on NCT04198623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04198623.